Jubi-R Injection is an antiviral drug that belongs to the category of purine nucleosides, containing the active ingredient Remdesivir. It is used in the treatment of coronavirus disease(COVID-19). It is an infectious respiratory disease caused by the severe acute respiratory syndrome named coronavirus 2 (SARS-CoV-2) virus. This drug is contraindicated in individuals with known hypersensitivity (allergic) reactions to the medication or any of its components. If an individual has previously experienced a severe allergic reaction to this drug, they should not receive the medication. Also, this use is contraindicated in patients with severe hepatic impairment and can cause severe liver-related adverse effects. Close monitoring of liver function is recommended during treatment with this drug. If significant liver function abnormalities are observed, treatment should be discontinued.